Special Considerations in the Management of HIV-Infected Patients From Minority Communities
Summary
- Participation in HIV clinical trials by minorities has increased but remains disproportionately low[Gifford 2002] ACTG 5095
- ACTG 5095 compared (zidovudine/lamivudine plus either abacavir, efavirenz, or both abacavir and efavirenz) in antiretroviral-naive patients[Gulick 2004]
- Study population was 36% blacks, 21% Latinos, and 40% non-Latino whites Polymorphism in the CYP2B6 Gene
- CASTLE
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content